Abstract:Conventionally, immunity in humans has been classified as innate and adaptive, with the concept that only the latter type has an immunological memory/recall response against specific antigens or pathogens. Recently, a new concept of trained immunity (a.k.a. innate memory response) has emerged. According to this concept, innate immune cells can exhibit enhanced responsiveness to subsequent challenges, after initial stimulation with antigen/pathogen. Thus, trained immunity enables the innate immune cells to respond robustly and non-specifically through exposure or re-exposure to antigens/infections or vaccines, providing enhanced resistance to unrelated pathogens or reduced infection severity. For example, individuals vaccinated with BCG to protect against tuberculosis were also protected from malaria and SARS-CoV-2 infections. Epigenetic modifications such as histone acetylation and metabolic reprogramming (e.g. shift towards glycolysis) and their inter-linked regulations are the key factors underpinning the immune activation of trained cells. The integrated metabolic and epigenetic rewiring generates sufficient metabolic intermediates, which is crucial to meet the energy demand required to produce proinflammatory and antimicrobial responses by the trained cells. These factors also determine the efficacy and durability of trained immunity. Importantly, the signaling pathways and regulatory molecules of trained immunity can be harnessed as potential targets for developing novel intervention strategies, such as better vaccines and immunotherapies against infectious (e.g., sepsis) and non-infectious (e.g., cancer) diseases. However, aberrant inflammation caused by inappropriate onset of trained immunity can lead to severe autoimmune pathological consequences, (e.g., systemic sclerosis and granulomatosis). In this review, we provide an overview of conventional innate and adaptive immunity and summarize various mechanistic factors associated with the onset and regulation of trained immunity, focusing on immunologic, metabolic, and epigenetic changes in myeloid cells. This review underscores the transformative potential of trained immunity in immunology, paving the way for developing novel therapeutic strategies for various infectious and non-infectious diseases that leverage innate immune memory.

Trained immunity-inducing vaccines: Harnessing innate memory for vaccine design and delivery

Innate Immune Memory Of Tissue-Resident Macrophages And Trained Innate Immunity: Re-Vamping Vaccine Concept And Strategies

Trained innate immunity: concept, nomenclature and future perspectives

Trained immunity: General and emerging concepts

New Tuberculosis Vaccine Strategies: Taking Aim at Un-Natural Immunity

Innate immune memory, trained immunity and nomenclature clarification

Trained immunity: adaptation within innate immune mechanisms.

The causes and consequences of trained immunity in myeloid cells

Trained immunity as a novel approach against COVID‐19 with a focus on Bacillus Calmette–Guérin vaccine: mechanisms, challenges and perspectives

Trained immunity-based vaccines for infections and allergic diseases

Lessons from Bacillus Calmette-Guérin: Harnessing Trained Immunity for Vaccine Development

Implications of vaccine non-specific effects on licensure of new vaccines

A Systematic Review: The Role of Resident Memory T Cells in Infectious Diseases and Their Relevance for Vaccine Development

Engineering Vaccines for Tissue‐Resident Memory T Cells

Defining trained immunity and its role in health and disease

The immune memory of innate immune systems

Trained Innate Immunity in Pediatric Infectious Diseases

Molecular and Cellular Mechanisms Modulating Trained Immunity by Various Cell Types in Response to Pathogen Encounter

Trained Immunity as an Adaptive Branch of Innate Immunity

Therapeutic targeting of trained immunity

From trained immunity in allergy to trained immunity‐based allergen vaccines